We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+26.99%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12.5B
AUM Growth
+$844M
Cap. Flow
-$1.62B
Cap. Flow %
-12.95%
Top 10 Hldgs %
33.14%
Holding
137
New
32
Increased
25
Reduced
37
Closed
18

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$331M
2
AON icon
Aon
AON
+$321M
3
WUBA
58.com Inc
WUBA
+$256M
4
BMY icon
Bristol-Myers Squibb
BMY
+$217M
5
TIF
Tiffany & Co.
TIF
+$191M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.65B
2
CI icon
Cigna
CI
+$142M
3
FIS icon
Fidelity National Information Services
FIS
+$135M
4
GD icon
General Dynamics
GD
+$132M
5
WAB icon
Wabtec
WAB
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 42.53%
2 Communication Services 18.4%
3 Technology 10.42%
4 Financials 7.52%
5 Industrials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIF
26
DELISTED
Tiffany & Co.
TIF
$186M 1.49%
+1,527,698
New +$191M
IOVA icon
27
Iovance Biotherapeutics
IOVA
$2.83B
$179M 1.44%
6,537,500
+787,500
+14% +$25.9M
NYT icon
28
New York Times
NYT
$10.2B
$174M 1.39%
+4,137,542
New +$150M
GD icon
29
General Dynamics
GD
$106B
$172M 1.38%
1,151,481
-932,200
-45% -$132M
ASND icon
30
Ascendis Pharma A/S
ASND
$16.8B
$169M 1.35%
1,140,000
-236,349
-17% -$32.5M
BMY.RT
31
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$158M 1.27%
44,200,000
+9,000,000
+26% +$32.5M
BX icon
32
Blackstone
BX
$110B
$157M 1.26%
2,768,319
+2,365,508
+587% +$125M
ALNY icon
33
Alnylam Pharmaceuticals
ALNY
$29.3B
$156M 1.24%
1,050,000
-450,000
-30% -$60.7M
QGEN icon
34
Qiagen
QGEN
$8.72B
$123M 0.99%
2,716,943
-75,431
-3% -$3.38M
WMGI
35
DELISTED
Wright Medical Group Inc
WMGI
$122M 0.98%
4,100,000
+1,825,000
+80% +$53.4M
FATE icon
36
Fate Therapeutics
FATE
$326M
$120M 0.96%
3,500,000
+500,000
+17% +$14.9M
PLYA
37
DELISTED
Playa Hotels & Resorts
PLYA
$111M 0.89%
30,606,930
– –
TRU icon
38
TransUnion
TRU
$15.3B
$104M 0.83%
1,192,747
-831,140
-41% -$66.3M
CZR
39
DELISTED
Caesars Entertainment Corporation
CZR
$97.2M 0.78%
+8,015,000
New +$81M
CI icon
40
Cigna
CI
$74.6B
$93.8M 0.75%
500,000
-750,000
-60% -$142M
ENTA icon
41
Enanta Pharmaceuticals
ENTA
$400M
$87.9M 0.7%
1,750,000
– –
MYOK
42
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$84.5M 0.68%
875,000
+445,000
+103% +$37.1M
SRPT icon
43
Sarepta Therapeutics
SRPT
$1.77B
$84.2M 0.67%
525,000
+175,000
+50% +$23.8M
EDU icon
44
New Oriental
EDU
$8.98B
$82.2M 0.66%
+631,000
New +$76.9M
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$74.2M 0.59%
650,000
+50,000
+8% +$4.85M
APLS
46
DELISTED
Apellis Pharmaceuticals
APLS
$73.5M 0.59%
2,250,000
+250,000
+13% +$8.03M
BRMK
47
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$67.9M 0.54%
7,170,213
– –
AGIO icon
48
Agios Pharmaceuticals
AGIO
$1.93B
$66.8M 0.54%
1,250,000
– –
KYNB
49
Kyntra Bio
KYNB
$29.4M
$65.9M 0.53%
65,000
+1,013
+2% +$941K
KRTX
50
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$64.1M 0.51%
575,000
+7,953
+1% +$691K
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Farallon Capital Management held 137 positions worth $12.5B, up 7.2% from $11.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management withdrew a net $1.62B in Q2 2020, closing 18 positions and reducing 37 holdings. Its most notable exit was Allergan plc, an estimated $1.65B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 52% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Farallon Capital Management opened a new position in T-Mobile US worth $360M.

  • Farallon Capital Management's largest Q2 2020 buy was T-Mobile US: 3,457,631 shares worth $360M.
  • Farallon Capital Management added most to Blackstone in Q2 2020, an estimated $125M increase.
  • Farallon Capital Management's biggest Q2 2020 reduction was Cigna, cutting an estimated $142M.
  • Farallon Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $1.65B.
  • Farallon Capital Management's ten largest holdings make up 33% of its $12.5B portfolio in Q2 2020.
  • Farallon Capital Management opened 32 new positions and closed 18 in Q2 2020.
  • Farallon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $12.5B.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.